Diverse Health Hub collects relevant and meaningful content for five therapeutic areas. Our focus allows us to organize and deliver health equity information regarding what is most important to you as a patient, patient care team member, or a healthcare provider.
Breast cancer survival and screening rates have improved significantly. However, incidence rates are higher among women of color and more often than not, these women are diagnosed at a later stage.
Kidney cancer (also called renal cell cancer, or renal cell adenocarcinoma) is a disease in which malignant cells are found in the lining of tubules in the kidney. There are 2 kidneys, one on each side of the backbone, above the waist. The tubules in the kidneys filter and clean the blood.
Sickle cell disease is a blood disorder caused by mutation, and it affects millions of people. Sickle cell is more common among people of certain ancestries, including those of African, Caribbean, Middle Eastern, Eastern Mediterranean, and Asian descent.
Multiple myeloma is a blood disorder that begins in the plasma cells. Studies have shown that minority populations are at an elevated risk for myeloma, yet are under-represented in research.
Clinical trials are responsible for numerous advancements in medicine and cures for a multitude of diseases. Evidence has shown that Hispanics, Asians and African-Americans are not adequately represented in clinical trials in the US.